🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11407+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11407 recruiting trials

NARecruitingNCT06700044

Probiotic Supplementation During Pregnancy in Women With High-Risk Pregnancies

🏥 Region Skane📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06726577

TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

🏥 Talengen Institute of Life Sciences, Shenzhen, P.R. China.📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06684119

Pediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)

👨‍⚕️ Anoopindar Bhalla, MD, Children's Hospital Los Angeles📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06566742

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

👨‍⚕️ Kelly Chien, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06558214

OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

👨‍⚕️ Ashley Ghiaseddin, MD, University of Florida📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06733740

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

👨‍⚕️ Yukun Luo, Chinese PLA General Hospital📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06792786

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

🏥 The Central Hospital of Lishui City📍 2 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06358469

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

👨‍⚕️ Amy Jamieson, University of British Columbia, Vancouver, BC, Canada📍 10 sites📅 Started Dec 2024View details ↗
Enrolling by InvitationNCT06805591

Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study

👨‍⚕️ Henrik W Schytz, MD, Ph.D. DMSc, Danish Headache Center📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06625684

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

👨‍⚕️ Quinn Ostrom, PhD, Duke University📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT07470684

Skin Involvement in Dupuytren Surgical Treatment Outcome

👨‍⚕️ Ilse Degreef, Prof. Dr., Universitaire Ziekenhuizen KU Leuven📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06667453

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

🏥 PepGen Inc📍 8 sites📅 Started Dec 2024View details ↗
NARecruitingNCT07175792

Accuracy of Motor Performance Perception in Multiple Sclerosis

🏥 Hasselt University📍 3 sites📅 Started Dec 2024View details ↗
NARecruitingNCT07430579

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

👨‍⚕️ Yunpeng Zhao, doctor, The Second Qilu Hospital of Shandong University📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06723951

QUALAS Validation in Dutch

👨‍⚕️ Lisette 't Hoen, MD, PhD, Erasmus Medical Center📍 2 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06636734

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

👨‍⚕️ Nicole C Schmitt, D, FACS, Emory University Hospital/Winship Cancer Institute📍 2 sites📅 Started Dec 2024View details ↗
NAEnrolling by InvitationNCT07233421

Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome

👨‍⚕️ Elina Hakonen, MD, PhD, New Children's Hospital, Helsinki University Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06597019

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 66 sites📅 Started Dec 2024View details ↗
Phase 1Enrolling by InvitationNCT06723106

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

👨‍⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 54 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06265766

Brain STimulation for Arm Recovery After Stroke 2

🏥 Jord Vink📍 16 sites📅 Started Dec 2024View details ↗
← PreviousPage 191 of 571Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →